Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Boston Scientific Co. (NYSE:BSX – Get Free Report) has been assigned an average recommendation of “Buy” from the twenty-three research firms that are presently covering the stock, MarketBeat.com ...

Scientists have developed an approach that combines rehabilitation robotics with spinal cord stimulation to restore movement in people with spinal cord injuries. The technology enhances ...

Madison Investment Advisors LLC purchased a new position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) during ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...